Business Risk

17/06/2024

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

13/06/2024

From dying mall brand to Wall Street winner: How Abercrombie & Fitch pulled off retail’s biggest comeback

21/05/2024

Lowe’s beats on earnings and revenue, even as consumers spend less on DIY projects

15/05/2024

Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone

13/05/2024

Shein’s U.S. charm offensive and IPO could hinge on NRF membership. So far, it’s been rejected

06/05/2024

Ex-CEO Howard Schultz says Starbucks needs to revamp its stores after big earnings miss

26/04/2024

Starbucks, Workers United made ‘significant progress’ in this week’s contract talks

17/04/2024

Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says

The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.

16/04/2024

Boeing defends 787 Dreamliner safety after whistleblower alleged structural flaws

11/04/2024

Department stores face another squeeze. This time, with store credit card revenue

09/04/2024

GM continues reinvention of Buick brand with new Enclave SUV

05/04/2024

Hyundai’s Genesis brand is a dark horse in U.S. luxury vehicle market